TY - JOUR
T1 - CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018
AU - The Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Cardiovascular Interventional Therapeutics (CVIT)
AU - Ozaki, Yukio
AU - Katagiri, Yuki
AU - Onuma, Yoshinobu
AU - Amano, Tetsuya
AU - Muramatsu, Takashi
AU - Kozuma, Ken
AU - Otsuji, Satoru
AU - Ueno, Takafumi
AU - Shiode, Nobuo
AU - Kawai, Kazuya
AU - Tanaka, Nobuhiro
AU - Ueda, Kinzo
AU - Akasaka, Takashi
AU - Hanaoka, Keiichi Igarashi
AU - Uemura, Shiro
AU - Oda, Hirotaka
AU - Katahira, Yoshiaki
AU - Kadota, Kazushige
AU - Kyo, Eisho
AU - Sato, Katsuhiko
AU - Sato, Tadaya
AU - Shite, Junya
AU - Nakao, Koichi
AU - Nishino, Masami
AU - Hikichi, Yutaka
AU - Honye, Junko
AU - Matsubara, Tetsuo
AU - Mizuno, Sumio
AU - Muramatsu, Toshiya
AU - Inohara, Taku
AU - Kohsaka, Shun
AU - Michishita, Ichiro
AU - Yokoi, Hiroyoshi
AU - Serruys, Patrick W.
AU - Ikari, Yuji
AU - Nakamura, Masato
N1 - Publisher Copyright:
© 2018, The Author(s).
PY - 2018/4/1
Y1 - 2018/4/1
N2 - While primary percutaneous coronary intervention (PCI) has significantly contributed to improve the mortality in patients with ST segment elevation myocardial infarction even in cardiogenic shock, primary PCI is a standard of care in most of Japanese institutions. Whereas there are high numbers of available facilities providing primary PCI in Japan, there are no clear guidelines focusing on procedural aspect of the standardized care. Whilst updated guidelines for the management of acute myocardial infarction were recently published by European Society of Cardiology, the following major changes are indicated; (1) radial access and drug-eluting stent over bare metal stent were recommended as Class I indication, and (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation. Although the primary PCI is consistently recommended in recent and previous guidelines, the device lag from Europe, the frequent usage of coronary imaging modalities in Japan, and the difference in available medical therapy or mechanical support may prevent direct application of European guidelines to Japanese population. The Task Force on Primary Percutaneous Coronary Intervention of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) has now proposed the expert consensus document for the management of acute myocardial infarction focusing on procedural aspect of primary PCI.
AB - While primary percutaneous coronary intervention (PCI) has significantly contributed to improve the mortality in patients with ST segment elevation myocardial infarction even in cardiogenic shock, primary PCI is a standard of care in most of Japanese institutions. Whereas there are high numbers of available facilities providing primary PCI in Japan, there are no clear guidelines focusing on procedural aspect of the standardized care. Whilst updated guidelines for the management of acute myocardial infarction were recently published by European Society of Cardiology, the following major changes are indicated; (1) radial access and drug-eluting stent over bare metal stent were recommended as Class I indication, and (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation. Although the primary PCI is consistently recommended in recent and previous guidelines, the device lag from Europe, the frequent usage of coronary imaging modalities in Japan, and the difference in available medical therapy or mechanical support may prevent direct application of European guidelines to Japanese population. The Task Force on Primary Percutaneous Coronary Intervention of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) has now proposed the expert consensus document for the management of acute myocardial infarction focusing on procedural aspect of primary PCI.
UR - http://www.scopus.com/inward/record.url?scp=85044842604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044842604&partnerID=8YFLogxK
U2 - 10.1007/s12928-018-0516-y
DO - 10.1007/s12928-018-0516-y
M3 - Review article
C2 - 29594964
AN - SCOPUS:85044842604
SN - 1868-4300
VL - 33
SP - 178
EP - 203
JO - Cardiovascular Intervention and Therapeutics
JF - Cardiovascular Intervention and Therapeutics
IS - 2
ER -